Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy

被引:0
作者
Kohei Shitara
Keisho Chin
Takaki Yoshikawa
Hitoshi Katai
Masanori Terashima
Seiji Ito
Motohiro Hirao
Kazuhiro Yoshida
Eiji Oki
Mitsuru Sasako
Yasunori Emi
Toshimasa Tsujinaka
机构
[1] National Cancer Center Hospital East,Department of Gastroenterology and Gastrointestinal Oncology
[2] Cancer Institute Hospital of JFCR,Department of Gastroenterology
[3] Kanagawa Cancer Center,Department of Gastrointestinal Surgery
[4] National Cancer Center Hospital,Gastric Surgery Division
[5] Shizuoka Cancer Center,Division of Gastric Surgery
[6] Aichi Cancer Center Hospital,Department of Gastroenterological Surgery
[7] National Hospital Organization Osaka National Hospital,Department of Surgery
[8] Gifu University Graduate School of Medicine,Department of Surgical Oncology
[9] Kyushu University,Department of Surgery and Science, Graduate School of Medical Sciences
[10] Hyogo College of Medicine,Department of Surgery
[11] Saiseikai Fukuoka General Hospital,Department of Surgery
[12] Kaizuka City Hospital,Department of Surgery
来源
Gastric Cancer | 2017年 / 20卷
关键词
Stage III gastric cancer; Adjuvant chemotherapy; Oxaliplatin; S-1; S-1 and oxaliplatin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:175 / 181
页数:6
相关论文
共 37 条
  • [1] Shirasaka T(2009)Development history and concept of an oral anticancer agent S-1 (TS-1): its clinical usefulness and future vistas Jpn J Clin Oncol 39 2-15
  • [2] Sakuramoto S(2007)Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 1810-1820
  • [3] Sasako M(2011)Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer J Clin Oncol 29 4387-4393
  • [4] Yamaguchi T(2012)Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial Lancet 379 315-321
  • [5] Kinoshita T(2011)Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer Cancer Chemother Pharmacol 67 1423-1428
  • [6] Fujii M(2015)Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer Ann Oncol 26 141-148
  • [7] Nashimoto A(2010)Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study) Ann Oncol 21 1001-1005
  • [8] Sasako M(undefined)undefined undefined undefined undefined-undefined
  • [9] Sakuramoto S(undefined)undefined undefined undefined undefined-undefined
  • [10] Katai H(undefined)undefined undefined undefined undefined-undefined